A first-in-man phase 1 trial for long-acting TransCon Growth Hormone

Gilfoyle, D; Mortensen, E; Christoffersen, ED; Leff, JA; Beckert, M

Christoffersen, ED (reprint author), Ascendis Pharma AS, Tuborg Blvd 5, DK-2900 Hellerup, Denmark.

GROWTH HORMONE & IGF RESEARCH, 2018; 39 (): 34

Abstract

TransCon growth hormone (GH) is a sustained-release inactive prodrug consisting of unmodified GH transiently bound to an inert carrier molecule design......

Full Text Link